Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazuo Morita
Effectiveness, Safety, and Methotrexate Dose-Tapering Pattern Over Two Years of Treatment With Adalimumab and ≥12 Mg/Week Methotrexate for Early Rheumatoid Arthritis: Results of the HAWK Postmarketing Surveillance Study in Japan
Modern Rheumatology
Medicine
Rheumatology
An Interstratified Mica-Montmorillonite Mineral in the Pyrophyllite Deposit at Kiriishi-Mine, Hiroshima Prefecture
Journal of the Mineralogical Society of Japan
Related publications
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Safety and Effectiveness of Adalimumab in Patients With Rheumatoid Arthritis Over 5 Years of Therapy in a Phase 3b and Subsequent Postmarketing Observational Study
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Long-Term Safety and Effectiveness of Adalimumab for the Treatment of Japanese Patients With Rheumatoid Arthritis: 3-Year Results From a Postmarketing Surveillance of 552 Patients
Modern Rheumatology
Medicine
Rheumatology
Safety of Low Dose Methotrexate in Elderly Patients With Rheumatoid Arthritis
Postgraduate Medical Journal
Medicine
Adalimumab With or Without Methotrexate in Juvenile Rheumatoid Arthritis
New England Journal of Medicine
Medicine
Achieving Comprehensive Disease Control in Patients With Early and Established Rheumatoid Arthritis Treated With Adalimumab Plus Methotrexate Versus Methotrexate Alone
RMD Open
Rheumatology
Allergy
Immunology
Combined Therapy With Prospidin and Methotrexate in Rheumatoid Arthritis (12 Months Controlled Study)
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Effectiveness of Subcutaneously Administered Methotrexate in Patients With Rheumatoid Arthritis
Advances in Clinical and Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Patient-Reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial
RMD Open
Rheumatology
Allergy
Immunology